Twist Bioscience Corporation Common Stock (TWST)
Twist Bioscience Corporation is a biotechnology company known for its innovative synthetic DNA manufacturing platform. Founded to enable rapid and cost-effective production of high-quality DNA, Twist serves a range of industries including healthcare, agriculture, and industrial applications. The company's platform utilizes a proprietary silicon-based synthesis process, allowing for high-throughput and scalable DNA synthesis essential for research, drug development, and diagnostics.
Company News
The DNA data storage market is expected to grow from $76 million in 2024 to $3,348 million by 2030, with a CAGR of 87.7%. The market is driven by increasing cybersecurity concerns and the need for secure, compact data storage solutions, particularly in healthcare and biotechnology sectors.
Twist Bioscience reported strong Q3 results with 18% revenue growth, achieving profitability through a one-time gain and improved operational efficiency. The company saw growth in Next Generation Sequencing and strategic product launches while managing slower Synthetic Biology segment performance.
Several mid-cap stocks, including Coeur Mining, Medical Properties Trust, and RH, saw significant gains last week. The article highlights the reasons behind the stock price increases for these companies.
Here is how Bicycle Therapeutics PLC Sponsored ADR (BCYC) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
Twist Bioscience's fiscal Q3 results show increased revenue and orders, innovative developments, and concerns over net losses and expenses. Read more here.
